Search Results - "Curtin, Bryan F."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Forskolin, an inducer of cAMP, up-regulates acetylcholinesterase expression and protects against organophosphate exposure in neuro 2A cells by Curtin, Bryan F, Pal, Nabaneeta, Gordon, Richard K, Nambiar, Madhusoodana P

    Published in Molecular and cellular biochemistry (01-10-2006)
    “…Bioscavenger prophylactic therapy using purified human acetylcholinesterase (AChE) or butylcholinesterase (BChE) is a promising treatment for future protection…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Organizing and Developing a GI Motility Lab in Community Practice: Challenges and Rewards by Baker, Jason R., Curtin, Bryan F., Moshiree, Baharak, Rao, Satish S. C.

    Published in Current gastroenterology reports (01-06-2022)
    “…Purpose of Review Neurogastroenterology and motility is a rapidly evolving subspecialty that encompasses over 33% of gastroenterological disorders, and up to…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Clostridium difficile-associated disease: adherence with current guidelines at a tertiary medical center by Curtin, Bryan F, Zarbalian, Yousef, Flasar, Mark H, von Rosenvinge, Erik

    Published in World journal of gastroenterology : WJG (14-12-2013)
    “…To assess adherence with the the Society for Healthcare Epidemiology of America (SHEA)/ the Infectious Diseases Society of America (IDSA) guidelines for…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia by Shah, Kamini, Curtin, Bryan F, Chu, Christopher, Hwang, Daniel, Flasar, Mark H, von Rosenvinge, Erik

    Published in World journal of clinical oncology (10-10-2017)
    “…To evaluate factors associated with infection (CDI) and outcomes of CDI in the myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) population…”
    Get full text
    Journal Article
  17. 17

    Unusually late-onset mycophenolate mofetil–related colitis by CURTIN, BRYAN F, RACHAKONDA, VIKRANT P, VON ROSENVINGE, ERIK C

    Published in American journal of health-system pharmacy (01-11-2014)
    “…PURPOSESerious gastrointestinal complications arising 13 years after the initiation of posttransplant immunosuppressant therapy with mycophenolate mofetil are…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Resveratrol induces catalytic bioscavenger paraoxonase 1 expression and protects against chemical warfare nerve agent toxicity in human cell lines by Curtin, Bryan F., Seetharam, Karthik I., Dhoieam, Pilin, Gordon, Richard K., Doctor, Bhupendra P., Nambiar, Madhusoodana P.

    Published in Journal of cellular biochemistry (01-04-2008)
    “…Current advances in enzyme bioscavenger prophylactic therapy against chemical warfare nerve agent (CWNA) exposure are moving towards the identification of…”
    Get full text
    Journal Article
  20. 20